Revive Therapeutics Ltd.
Revive Therapeutics Ltd.
CSE Index:
CSE CompositeCurrency:
CAD Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Emergency Use Authorization, Orphan Drug, Fast Track, and Breakthrough Therapy designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various programs. For more information visit www.ReviveThera.com.
Revive Therapeutics Ltd. (RVV)
0.035
0.005 (16.67%)
Revive Therapeutics Ltd. (RVV)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
853,000
Bid Price
0.03
Ask Price
0.035
Ask Size
459,000
Volume
274,262
Last Price
0.035
Tick
Net Change
0.005
Prev Close
0.03
Open
0.03
Day High
0.035
Day Low
0.03
52 Week High
0.035
52 Week Low
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
55,000
Bid Price
0.03
Ask Price
0.00
Ask Size
0
Volume
47,000
Last Price
0.03
Tick
Net Change
-0.005
Prev Close
0.035
Open
0.035
Day High
0.035
Day Low
0.03
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
853,000
Bid Price
0.03
Ask Price
0.035
Ask Size
459,000
Volume
274,262
Last Price
0.035
Tick
Net Change
0.005
Prev Close
0.03
Open
0.03
Day High
0.035
Day Low
0.03
52 Week High
0.035
52 Week Low
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
55,000
Bid Price
0.03
Ask Price
0.00
Ask Size
0
Volume
47,000
Last Price
0.03
Tick
Net Change
-0.005
Prev Close
0.035
Open
0.035
Day High
0.035
Day Low
0.03
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| BMO Nesbitt Burns Inc. | 260,000 | 0.03 | 0.035 | 50,000 | Scotia Capital Inc. |
| iA Private Wealth Inc. | 100,000 | 0.03 | 0.035 | 160,000 | Interactive Brokers Canada Inc. |
| TD Securities Inc. | 3,000 | 0.03 | 0.035 | 189,000 | National Bank Financial Inc. |
| TD Securities Inc. | 22,000 | 0.03 | 0.035 | 18,000 | TD Securities Inc. |
| TD Securities Inc. | 50,000 | 0.03 | 0.035 | 38,000 | TD Securities Inc. |
| TD Securities Inc. | 40,000 | 0.03 | 0.035 | 4,000 | Raymond James Ltd. |
| Scotia Capital Inc. | 22,000 | 0.03 | 0.04 | 30,000 | Scotia Capital Inc. |
| National Bank Financial Inc. | 3,000 | 0.03 | 0.04 | 1,000 | Questrade Inc. |
| RBC Capital Markets | 3,000 | 0.03 | 0.04 | 168,000 | CIBC World Markets Inc. |
| BMO Nesbitt Burns Inc. | 250,000 | 0.03 | 0.04 | 1,000 | Questrade Inc. |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| Instinet Canada Limited | 55,000 | 0.03 | 0.00 | 0 | |
| Instinet Canada Limited | 50,000 | 0.015 | 0.00 | 0 | |
| Instinet Canada Limited | 70,000 | 0.015 | 0.00 | 0 | |
| Anonymous | 100,000 | 0.01 | 0.00 | 0 | |
| Instinet Canada Limited | 100,000 | 0.005 | 0.00 | 0 | |
| Anonymous | 600,000 | 0.005 | 0.00 | 0 | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 11 | 853,000 | 0.03 | 0.035 | 459,000 | 6 |
| 5 | 270,000 | 0.025 | 0.04 | 331,000 | 10 |
| 7 | 359,000 | 0.02 | 0.045 | 211,000 | 5 |
| 13 | 485,000 | 0.015 | 0.05 | 48,000 | 5 |
| 14 | 1,430,000 | 0.01 | 0.055 | 12,000 | 3 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 1 | 55,000 | 0.03 | 0.00 | 0 | 0 |
| 2 | 120,000 | 0.015 | 0.00 | 0 | 0 |
| 1 | 100,000 | 0.01 | 0.00 | 0 | 0 |
| 2 | 700,000 | 0.005 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Apr 17, 16:07 | 0.03 | 0.00 | 5,000 | Instinet Canada Limited | TD Securities Inc. | CSE2 |
| Apr 17, 15:42 | 0.035 | 0.005 | 2,000 | TD Securities Inc. | TD Securities Inc. | CSE |
| Apr 17, 14:16 | 0.035 | 0.005 | 6,000 | TD Securities Inc. | TD Securities Inc. | CSE |
| Apr 17, 14:10 | 0.035 | 0.005 | 20,000 | TD Securities Inc. | Instinet Canada Limited | CSE2 |
| Apr 17, 14:09 | 0.035 | 0.005 | 27,000 | TD Securities Inc. | TD Securities Inc. | CSE |
Company Info
Address
The Canadian Venture Building
82 Richmond Street East
Toronto, ON M5C 1P1
CanadaPhone
888 901-0036Fax
905-248-3355Email
info@revivethera.comWebsite
http://www.revivethera.comListing date
Tuesday, July 23, 2019Transfer Agent
Marrelli Trust Company LimitedAuditor
DNTW LLPSEDAR Information
Filing Type
Any
News Releases
Management's Discussion & Analysis
Financial Statements
Material Change Report
Timeframe
1 week1 month3 month6 month1 yearAll Time
Revive Therapeutics Ltd.
Date:
Jan 8, 2025
Revive Therapeutics Ltd.
Date:
Oct 28, 2024
Revive Therapeutics Ltd.
Date:
Oct 28, 2024
Revive Therapeutics Ltd.
Date:
Feb 23, 2024
Revive Therapeutics Ltd.
Date:
Dec 19, 2023
Revive Therapeutics Ltd.
Date:
Oct 27, 2023
Revive Therapeutics Ltd.
Date:
Oct 27, 2023
Revive Therapeutics Ltd.
Date:
Jan 23, 2023
Revive Therapeutics Ltd.
Date:
Oct 28, 2022
Revive Therapeutics Ltd.
Date:
Oct 28, 2022
Revive Therapeutics Ltd.
Date:
Jul 29, 2022
Revive Therapeutics Ltd.
Date:
Jun 29, 2022
Revive Therapeutics Ltd.
Date:
Oct 25, 2021
Revive Therapeutics Ltd.
Date:
Oct 25, 2021
Revive Therapeutics Ltd.
Date:
Mar 1, 2021
Revive Therapeutics Ltd.
Date:
Jan 26, 2021
Revive Therapeutics Ltd.
Date:
Jan 26, 2021
Revive Therapeutics Ltd.
Date:
Jan 26, 2021
Revive Therapeutics Ltd.
Date:
Jan 26, 2021
Revive Therapeutics Ltd.
Date:
Jan 26, 2021
Revive Therapeutics Ltd.
Date:
Oct 28, 2020
Revive Therapeutics Ltd.
Date:
Oct 28, 2020
Revive Therapeutics Ltd.
Date:
Apr 17, 2020
Revive Therapeutics Ltd.
Date:
Mar 30, 2020
Revive Therapeutics Ltd.
Date:
Oct 25, 2019
Revive Therapeutics Ltd.
Date:
Oct 25, 2019
Revive Therapeutics Ltd.
Date:
Oct 24, 2019
Revive Therapeutics Ltd.
Date:
Feb 14, 2019
Revive Therapeutics Ltd.
Date:
Oct 26, 2018
Revive Therapeutics Ltd.
Date:
Oct 26, 2018
Revive Therapeutics Ltd.
Date:
Oct 19, 2017
Revive Therapeutics Ltd.
Date:
Oct 19, 2017
Revive Therapeutics Ltd.
Date:
Oct 20, 2016
Revive Therapeutics Ltd.
Date:
Aug 31, 2016
Revive Therapeutics Ltd.
Date:
Aug 25, 2016
Revive Therapeutics Ltd.
Date:
Oct 21, 2015
Revive Therapeutics Ltd.
Date:
Oct 8, 2014
Revive Therapeutics Ltd.
Date:
Oct 8, 2014
Revive Therapeutics Ltd.
Date:
Sep 24, 2014
Revive Therapeutics Ltd.
Date:
Feb 27, 2014
Revive Therapeutics Ltd.
Date:
Feb 27, 2014
Revive Therapeutics Ltd.
Date:
Aug 19, 2013
Revive Therapeutics Ltd.
Date:
Aug 19, 2013
Revive Therapeutics Ltd.
Date:
Apr 29, 2013
Revive Therapeutics Ltd.
Date:
Apr 29, 2013
Company Info
Address
The Canadian Venture Building
82 Richmond Street East
Toronto, ON M5C 1P1
CanadaPhone
888 901-0036Fax
905-248-3355Email
info@revivethera.comWebsite
http://www.revivethera.comListing date
Tuesday, July 23, 2019Transfer Agent
Marrelli Trust Company LimitedAuditor
DNTW LLPCapitalization
Issued & Outstanding:
418564269Reserved for Issuance:
77666709Bulletins
19/07/2019
2019-0718 – New Listing - Revive Therapeutics Ltd. (RVV)
le 19 juillet/July 2019
The common shares of Revive Therapeutics Ltd. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
